View Archive »
About The Cover
The cover for issue 32 of Oncotarget features Figure 2, "This figure depicts overall survival and local in-brain recurrence-free survival in the study’s subgroups," by Hussein, et al.
|
|
Table of Contents
Research Papers
|
| Survival after resection of brain metastases with white light microscopy versus fluorescence-guidance: A matched cohort analysis of the Metastasys study data |
|
https://doi.org/10.18632/oncotarget.27688
Abdelhalim Hussein, Veit Rohde, Christina Wolfert, Silvia Hernandez-Duran, Ingo Fiss, Annalen Bleckmann, Alonso Barrantes Freer, Dorothee Mielke, Bawarjan Schatlo
|
| 3026-3034 |
|
| Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL |
|
https://doi.org/10.18632/oncotarget.27691
Yaya Chu, Aradhana Awasthi, Sanghoon Lee, Dina Edani, Changhong Yin, Jessica Hochberg, Tishi Shah, Tae-Hoon Chung, Janet Ayello, Carmella van de Ven, Christian Klein, Dean Lee, Mitchell S. Cairo
|
| 3035-3047 |
|
| Losartan improves the therapeutic effect of metronomic cyclophosphamide in triple negative mammary cancer models |
|
https://doi.org/10.18632/oncotarget.27694
Leandro E. Mainetti, María José Rico, Cintia Daniela Kaufman, Monica Carolina Grillo, Julian Guercetti, María Virginia Baglioni, Antonela Del Giúdice, Maria Celeste Capitani, Matias Fusini, Viviana Rosa Rozados, O. Graciela Scharovsky
|
| 3048-3060 |
|
| Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients |
|
https://doi.org/10.18632/oncotarget.27695
Aman Chauhan, Riham El-Khouli, Timothy Waits, Rohitashva Agrawal, Fariha Siddiqui, Zachary Tarter, Millicent Horn, Heidi Weiss, Elizabeth Oates, B. Mark Evers, Lowell Anthony
|
| 3061-3068 |
|
| Preclinical evaluation of the anti-tumor activity of pralatrexate in high-risk neuroblastoma cells |
|
https://doi.org/10.18632/oncotarget.27697
Rachael A. Clark, Sora Lee, Jingbo Qiao, Dai H. Chung
|
| 3069-3077 |
Reviews
|
| Important players in carcinogenesis as potential targets in cancer therapy: an update |
|
https://doi.org/10.18632/oncotarget.27689
Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Dariusz Pawlak
|
| 3078-3101 |
Corrections
|
| Correction: LRP6 promotes invasion and metastasis of colorectal cancer through cytoskeleton dynamics |
|
https://doi.org/10.18632/oncotarget.27710
Qian Yao, Yu An, Wei Hou, Ya-Nan Cao, Meng-Fei Yao, Ning-Ning Ma, Lin Hou, Hong Zhang, Hai-Jing Liu, Bo Zhang
|
| 3102-3102 |
|
| Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells |
|
https://doi.org/10.18632/oncotarget.27597
Sham S. Kakar, Seema Parte, Kelsey Carter, Irving G. Joshua, Christopher Worth, Pranela Rameshwar, Mariusz Z. Ratajczak
|
| 3103-3104 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
